Literature DB >> 12458135

Molecular epidemiology and antibiotic resistance of Enterobacter spp. from three distinct populations in Grampian, UK.

F M E Wagenlehner1, F M MacKenzie, K J Forbes, I M Gould.   

Abstract

The distribution of Enterobacter spp. within the population of Aberdeen Royal Infirmary was compared with the outpatient population with regard to molecular epidemiology and antibiotic resistance. Enterobacter spp. from 60 patients and one environmental site were characterised as ITU, non ITU and outpatients' isolates. Thirty-five percent were blood culture isolates. Cefotaxime resistant strains in the hospital were frequent. Cefotaxime (64%) sensitive isolates were inducible for hyperproduction of Bush group 1 beta-lactamase. Isolates were further investigated by PFGE. Isolates (27%) were clonally related and typed in four clusters. Consecutive isolates were studied in selected patients showing minor genomic changes. One environmental isolate from a deep sink at ITU was related to a patient's isolate. Copyright 2002 Elsevier Science B.V. and International Society of Chemotherapy

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458135     DOI: 10.1016/s0924-8579(02)00179-6

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  MALDI-TOF MS as a Tool To Detect a Nosocomial Outbreak of Extended-Spectrum-β-Lactamase- and ArmA Methyltransferase-Producing Enterobacter cloacae Clinical Isolates in Algeria.

Authors:  Nour Chems el Houda Khennouchi; Lotfi Loucif; Nafissa Boutefnouchet; Hamoudi Allag; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

2.  Ceftolozane-tazobactam and Fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: Case report and review of the literature.

Authors:  Antonella Frattari; Vincenzo Savini; Ennio Polilli; Donatella Cibelli; Silvia Talamazzi; Donatella Bosco; Augusta Consorte; Paolo Fazii; Giustino Parruti
Journal:  IDCases       Date:  2018-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.